For: | Yu J, Lv YM, Yang P, Jiang YZ, Qin XR, Wang XY. Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection. World J Gastroenterol 2023; 29(20): 3133-3144 [PMID: PMC10280792 DOI: 10.3748/wjg.v29.i20.3133] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i20/3133.htm |
Number | Citing Articles |
1 |
Valerie Josephine Dirjayanto, Jessica Audrey, Daniel Martin Simadibrata. Vonoprazan-amoxicillin dual regimen with <i>Saccharomyces boulardii</i> as a rescue therapy for <i>Helicobacter pylori</i>: Current perspectives and implications. World Journal of Gastroenterology 2024; 30(10): 1280-1286 doi: 10.3748/wjg.v30.i10.1280
Abstract(470) |
Core Tip(511) |
Full Article(HTML)(2548)
|
Full Article with Cover (PDF)-823K(114)
|
Full Article (Word)-173K(0)
|
Audio-1404K(7)
|
Peer-Review Report-216K(46)
|
Answering Reviewers-96K(46)
|
Full Article (PDF)-570K(140)
|
Full Article (XML)-94K(45)
|
Times Cited (1)
|
Total Visits (5206)
|
Open
|
2 |
Jie Zhang, Xin Cao, Kai Ma, Yizhou Jiang, Xiangrong Qin, Xiaoyong Wang. Safety and effectiveness of dual therapy for Helicobacter pylori infection and the effect on the glycated hemoglobin level in type 2 diabetes. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-85628-5
|